Search Results 671-680 of 18363 for Hepatitis b

  1. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

    ... B-cell Hematologic Malignancies. Print details. Share; Facebook ... Patients with active hepatitis B or hepatitis C infections are excluded from the study.

  2. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    ... hepatitis B surface antibody [HBsAb] positive, and hepatitis B core antibody [HBcAb] negative are eligible for the study);; Patients with positive HBcAb are ...

  3. Primary Care in Arizona - Doctors - Mayo Clinic

    Horsley, M.D.. Internist. Phoenix, AZ. Areas of focus: LGBT health care, Erectile dysfunction, Sexual dysfunction, Hepatitis C, Hepatitis B, Sexually ...

  4. Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma - Mayo Clinic

    For Hepatitis B, this includes positive tests for both Hepatitis B surface antigen and quantitative Hepatitis B polymerase chain reaction (PCR). For ...

  5. Deucravacitinib (BMS-986165) in LPP and FFA - Mayo Clinic

    Positive for hepatitis B core antibody (HBcAb) and positive for hepatitis B virus deoxyribonucleic acid (HBV DNA). Note: Patients who are HBcAb-positive and ...

  6. Buprenorphine (intradermal route) - Side effects & uses - Mayo Clinic

    Hepatitis B or C, history of or; Hypokalemia (low potassium in the blood) or; Hypomagnesemia (low magnesium in the blood), severe or; Hypothyroidism (an ...

  7. Prerequisites and Requirements - M.D. Program - Mayo Clinic Alix School of Medicine

    For more information on Hepatitis B requirements, visit the Association of American Medical Colleges (AAMC) Hep B FAQs . COVID-19: Learners should provide ...

  8. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    can be enrolled if a confirmatory negative hepatitis C RNA test is obtained - Is seropositive for hepatitis B (defined by a positive test for hepatitis B ...

  9. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

    - Current hepatitis C infection. - Current hepatitis B infection. - History of alcohol or substance abuse ≤6 months of Screening that would limit

  10. Combination Chemotherapy or 90-Yttrium Ibritumomab Tiuxetan and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Relapsed Diffuse Large B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Active evidence of Hepatitis B or C infection; Hepatitis B surface antigen positive. Patients who have had prior radiation to the lung will be excluded from ...